Meeting
2016 ASCO Annual Meeting
PD-1, PD-L1, and B7-H3 expression in Human Immunodeficiency Virus (HIV) infected patients with aerodigestive (AD) cancers (CA).
Authors
Katherine Ann Scilla
University of Maryland Greenebaum Cancer Center, Baltimore, MD
Katherine Ann Scilla , Jonathon Heath , Olga B. Ioffe , Ashley L Cellini , Martin J. Edelman , Dan Paul Zandberg , David Riedel , Josephine Louella Feliciano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11607)
DOI
10.1200/JCO.2016.34.15_suppl.11607
Abstract #
11607
Poster Bd #
304
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Case-control study of PD-1, PD-L1 and B7-H3 expression in lung cancer (CA) patients (pts) with and without human immunodeficiency virus (HIV) infection.
First Author: Katherine Ann Scilla
Poster
2016 ASCO Annual Meeting
Objective measurement and significance of PD-L1, B7-H3, B7-H4 and TILs in Small Cell Lung Cancer (SCLC).
First Author: Kurt Alex Schalper
Poster
2016 ASCO Annual Meeting
Immunogenicity of clear cell ovarian cancer: Association with ARID1A loss, microsatellite instability and endometriosis.
First Author: Kyle Strickland
Poster
2016 Gastrointestinal Cancers Symposium
Could the PD-1 pathway be a potential target for treating small intestinal adenocarcinoma?
First Author: Chanjuan Shi